Magoya, Japan

Yohei Iwata

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Duke University. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yohei Iwata. Retrieved from https://idiyas.com/inventor/yohei-iwata-waubl1g1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Yohei Iwata in Immunology

Introduction

Yohei Iwata, located in Magoya, Japan, stands out as a notable inventor in the field of immunology. With a focus on regulatory B cells and their therapeutic applications, he has made significant strides in understanding the immune response, particularly in the realm of inflammatory diseases.

Latest Patents

Iwata holds one patent titled "Regulatory B cells and their uses." This invention pertains to a unique subset of B cells known as B10 cells, which play a critical role in regulating T cell-mediated inflammatory responses through the secretion of interleukin-10 (IL-10). His patent details several potential applications of B10 cells in manipulating immune responses and treating diseases. Notably, it discusses therapeutic strategies that involve the adoptive transfer of B10 cells and enhancing their levels to combat autoimmune or inflammatory conditions. Additionally, the invention highlights methods for ablation or inhibition of B10 cells to improve immunodeficient states, treat infectious diseases, and tackle tumors or cancers, along with diagnostic applications.

Career Highlights

Yohei Iwata is affiliated with Duke University, where he applies his research to foster advancements in immunology. His work is pivotal in pushing the boundaries of how regulatory B cells can be harnessed for therapeutic purposes. The impact of his innovations is notable in addressing significant health challenges related to immune and inflammatory diseases.

Collaborations

Iwata collaborates with esteemed colleagues, including Thomas F. Tedder and Takashi Matsushita. Their combined expertise contributes to the advancement of innovative solutions in the treatment of immune-related diseases, enhancing the understanding of B cell functionality in immunological contexts.

Conclusion

The contributions of Yohei Iwata to the field of immunology, particularly through his patent on regulatory B cells, exemplify the importance of innovation in medicine. His commitment to research and collaboration at Duke University positions him at the forefront of developing therapeutic strategies that could significantly improve patient outcomes in autoimmune and inflammatory conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…